Physician profile

Scott Eisenberg

Cardiovascular Disease · Eatontown, NJ

NPI 1891778353

$131,738.74

in general payments reported to CMS, 2019-2025

49 companies · $2,614 in 2025

The $2,614 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$7,747.70
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$2,580.00
Education$367.81

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Janssen Pharmaceuticals, INC $68,392.43 2019-2024 Xarelto
Astrazeneca Pharmaceuticals LP $45,594.62 2019-2025 Farxiga, Lynparza
Novartis Pharmaceuticals Corporation $4,443.44 2019-2025
Esperion Therapeutics, INC. $2,218.08 2020-2025 Nexletol
Actelion Pharmaceuticals US, INC. $1,821.53 2019-2025 Uptravi, Opsumit, Opsynvi
Boston Scientific Corporation $1,471.66 2019-2025 Watchman Flx, Avvigo Guidance System, Bodyguardian
Amgen INC. $920.97 2020-2025 Repatha, Repatha
Boehringer Ingelheim Pharmaceuticals, INC. $544.02 2019-2025 Jardiance
Merck Sharp & Dohme LLC $493.99 2021-2025 Verquvo, Winrevair, Capvaxive
Irhythm Technologies, INC. $478.00 2022-2024 Zio Xt Patch, Zio Monitor
E.R. Squibb & Sons, L.L.C. $452.52 2019-2025 Eliquis, Camzyos
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $399.46 2019-2025 Lifevest
Kowa Pharmaceuticals America, INC. $297.19 2019-2023 Livalo
Pfizer INC. $284.85 2019-2025
United Therapeutics Corporation $278.81 2019-2025 Tyvaso, Tyvaso
Show all 49 companies
CompanyGeneral paymentsYearsTop products
Sanofi-Aventis U.S. LLC $255.29 2019-2023
Bayer Healthcare Pharmaceuticals INC. $229.32 2019-2025
Medtronic, INC. $215.85 2021-2025 Micra, Onyx Frontier
Arbor Pharmaceuticals, INC. $215.21 2019-2021
Abbott Laboratories $200.20 2021-2024 Accent, Aveir, Jot Dx
Amarin Pharma, INC. $194.60 2019-2023
Acist Medical Systems, INC. $190.26 2023-2024
Abiomed $173.69 2019-2025 Impella
Regeneron Healthcare Solutions, INC. $169.51 2019-2025 Evkeeza
Bard Peripheral Vascular, INC. $161.19 2025 Rotarexs 6 F X 135 Cm
Cvrx, INC. $153.89 2021-2024 Barostim Neo System
Kiniksa Pharmaceuticals, LTD. $141.76 2021-2023 Arcalyst
Atricure, INC. $139.45 2023-2025 Synergy Ablation System, Atriclip Laa Exclusion System
Novo Nordisk INC $134.75 2024-2025 Wegovy, Ozempic, Rybelsus
Kestra Medical Technology Services, INC. $102.36 2024-2025 Assure Wcd
W. L. Gore & Associates, INC. $102.16 2021-2022
Alnylam Pharmaceuticals INC. $102.02 2024-2025 Onpattro, Amvuttra
Lundbeck LLC $96.44 2019-2020
Genzyme Corporation $79.17 2021-2024
Silk Road Medical, INC. $78.40 2023-2024 Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter
Glaxosmithkline, LLC. $66.65 2025 Shingrix
Philips North America LLC $54.65 2024-2025 (5044) Mcot, Lm Accessories
Tactile Systems Technology INC $52.91 2025 Flexitouch Plus, Nimbl
Chiesi USA, INC. $46.46 2025 Juxtapid
Akcea Therapeutics, INC. $40.27 2019-2021
Aegerion Pharmaceuticals, INC. $37.92 2019
Agepha Pharma Fz LLC $35.07 2024-2025 Lodoco
Kiniksa Pharmaceuticals International, Plc $35.00 2024 Arcalyst
Corcept Therapeutics $32.75 2024-2025 Korlym
Bridgebio Pharma, INC. $32.09 2025 Attruby
Imperative Care, INC $29.60 2025 Prodigy Catheter
Daiichi Sankyo INC. $17.68 2023 Injectafer
Scpharmaceuticals INC. $15.60 2025
Bardy Diagnostics, INC. $15.00 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Scott Eisenberg

$131,738.74

in general payments reported 2019-2025

Years
2019-2025
Top company
Janssen Pharmaceuticals, INC
Context
The $2,614 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/86147/scott-eisenberg

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.